Clinical Trials Directory

Trials / Suspended

SuspendedNCT05513859

Investigational Imaging Technique During Brain Surgery

Towards In-Vivo, Intraoperative Image Guided Brain Tumor Margin Assessment With Quantitative Oblique Back Illumination Microscopy

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
24 (estimated)
Sponsor
Emory University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This early phase I trial tests the safety and reliability of an investigational imaging technique called quantitative oblique back illumination microscopy (qOBM) during brain surgery for detecting brain tumors and brain tumor margins in patients with glioblastoma, astrocytoma, or oligodendroglioma. Surgical margins refer to the edge or border of the tissue removed in cancer surgery. qOBM may be able to assess and reveal brain tumor surgical margins in a more safe and reliable manner.

Detailed description

PRIMARY OBJECTIVE: I. To perform a first-in-human study to assess the ability of a quantitative oblique back illumination microscopy (qOBM) handheld device to safely and reliably image brain tumor pathology intraoperatively in-situ and in-vivo. SECONDARY OBJECTIVES: I. To characterize the biophysical and structural features that enable detection of bulk tumor and tumor margins, including infiltrative disease, with qOBM. II. To develop qOBM imaging probes with multimodal capabilities (analog black and white and color imaging, fluorescent imaging) and with the potential to clearly reveal brain tumor margins ex vivo and in vivo during neurosurgical procedures. OUTLINE: Patients undergo craniotomy with intraoperative ex vivo and in situ tumor assessment with qOBM. Patients then undergo postoperative exam with computed tomography (CT) or magnetic resonance imaging (MRI) any of days 1-5 after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURECraniotomyUndergo craniotomy
DEVICEQuantitative Oblique Back-Illumination MicroscopyUndergo intraoperative microscopy utilizing qOBM

Timeline

Start date
2024-03-11
Primary completion
2026-06-28
Completion
2027-06-23
First posted
2022-08-24
Last updated
2025-06-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05513859. Inclusion in this directory is not an endorsement.